Veterinary Medicines

SALICYLINE 50 % PO

Authorised
  • Acetylsalicylic acid
Download as PDF

Product identification

Medicine name:
SALICYLINE 50 % PO
Active substance:
  • Acetylsalicylic acid
Target species:
  • Chicken (broiler)
  • Pig
  • Equid
  • Sheep (lamb)
  • Goat (kid)
  • Cattle (calf)
  • Poultry
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Acetylsalicylic acid
    0.50
    gram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Chicken (broiler)
      • Meat and offal
        1
        day
    • Pig
      • Meat and offal
        1
        day
    • Equid
      • Meat and offal
        7
        day
    • Sheep (lamb)
      • Meat and offal
        7
        day
    • Goat (kid)
      • Meat and offal
        7
        day
    • Cattle (calf)
      • Meat and offal
        7
        day
    • Poultry
      • Meat and offal
        7
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02BA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7287459 0/2003
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/11/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
Download